We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ROPIVACAINE READYFUSOR ropivacaine hydrochloride 0.2% solution for injection, bottle in dispenser device, BioQ Pharma Pty Ltd, CON-873
Product name
ROPIVACAINE READYFUSOR ropivacaine hydrochloride 0.2% solution for injection, bottle in dispenser device
Sponsor name
BioQ Pharma Pty Ltd
ARTG details
- 267572
Consent start
Consent no.
CON-873
Duration
The consent is effective from 14 October 2021 until 13 October 2022.
Standard
Subsections 7(2) and 9(5), and subparagraphs 9(3)(a)(i) and 9(1)(f)(i), of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The product does not conform to the requirements of Therapeutic Goods Order No.
91 - Standard for labels of prescription and related medicines, in that the
product label does not have text at the minimum height required, does not
include the name and quantity of the active ingredient immediately below the
name of the product on the main panel, and does not include the approved route
of administration on the main panel.
Import, Supply, &/or Export
Import and supply
Therapeutic product type
Prescription medicines